OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

• Aboulker J,
• Guérin C,
• Flys C,
• Jackson A,
• Ben Hamouda N,
• Poizot-Martin I,
• Bonnet B,
• Pialoux G,
• Lelièvre J,
• Hénin Y,
• Cuzin,
• Surenaud M,
• Desaint C,
• Durier C,
• Salmon-Céron D,
• Choppin J,
• Launay O

Affiliations

Aboulker J

Guérin C

Flys C

Jackson A

Ben Hamouda N

Poizot-Martin I

Bonnet B

Pialoux G

Lelièvre J

Hénin Y

Cuzin

Surenaud M

Desaint C

Durier C

Salmon-Céron D

Choppin J

Launay O